ANIX
Anixa Biosciences Inc
2.80$
+1.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.3% | -7.7% | -75.0% | -100.0% | – | – | +0.0% | +0.0% | +11.1% | – | – | – | |
| – | -109.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -16.5% | +42.7% | +0.0% | -23.3% | +5.1% | -14.8% | -20.2% | +8.2% | -3.5% | +14.2% | +5.4% | – | |
| – | +57.4% | -26.2% | +0.0% | +1.2% | +8.7% | -8.3% | -17.8% | +25.6% | -6.9% | -13.9% | +1.6% | – | |
| – | +18.3% | -0.5% | +0.0% | -11.9% | +7.1% | -11.3% | -18.9% | +17.7% | -5.3% | -2.5% | +3.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.